Fibrocell Science Inc.
FCSC
FCSC was delisted on the 12th of December, 2019.
20 hedge funds and large institutions have $6.1M invested in Fibrocell Science Inc. in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 7 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
16% more capital invested
Capital invested by funds: $5.28M → $6.1M (+$822K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less funds holding
Funds holding: 23 → 20 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$472K |
| 2 |
Renaissance Technologies
New York
|
+$417K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$173K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$76.7K |
| 5 |
Millennium Management
New York
|
+$28.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$77K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
-$56.2K |
| 3 |
ACA
Apis Capital Advisors
New York
|
-$48K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$26K |
| 5 |
MFW
Mosaic Family Wealth
St. Louis,
Missouri
|
-$4K |
FCSC Hedge Fund Activity: Q2 2019 in Review
20 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q2 2019, worth a combined $6.1M — up 16% from $5.28M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of FCSC and 4 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Vanguard Group, adding an estimated $472K. The largest seller was Virtu Financial, exiting entirely with an estimated $77K sold.
- 20 institutional investors held Fibrocell Science Inc. (FCSC) as of Q2 2019, down from 23 in Q1 2019.
- Funds reported $6.1M of Fibrocell Science Inc. stock for Q2 2019, up 16% quarter-over-quarter.
- 4 funds opened new Fibrocell Science Inc. positions in Q2 2019 and 7 closed out, a net change of -3 holders.
- The largest Fibrocell Science Inc. buyer in Q2 2019 was Vanguard Group, an estimated $472K added.
- The largest Fibrocell Science Inc. seller in Q2 2019 was Virtu Financial, an estimated $77K sold.
Based on aggregated 13F filings for Q2 2019.